Services
Research
Training
Industry
About us
ChEBI
Examples:
iron*
,
InChI=1S/CH4O/c1-2/h2H,1H3
,
caffeine
Advanced
Home
Advanced Search
Browse
Documentation
Download
Tools
About ChEBI
Submit
Contact us
DiNA
Statistics
Entity of the Month
Periodic Table
Ontology
Train online
User Manual
Annotation Manual
Developer Manual
FAQ's
BiNChE
libChEBI
Web Services
ChEBI
> Main
CHEBI:145421 - rigosertib sodium
Main
ChEBI Ontology
Automatic Xrefs
Reactions
Pathways
Models
ChEBI Name
rigosertib sodium
ChEBI ID
CHEBI:145421
Definition
The sodium salt of rigosertib. It is an anti-cancer agent which has been granted Orphan Drug Designation by the FDA for use in patients with myelodysplastic syndromes (MDS).
Stars
This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download
Molfile
XML
SDF
Find compounds which contain this structure
Find compounds which resemble this structure
Take structure to the Advanced Search
Formula
C21H24NO8S.Na
Net Charge
0
Average Mass
473.470
Monoisotopic Mass
473.11203
InChI
InChI=1S/C21H25NO8S.Na/c1-
27-
15-
10-
19(29-
3)
16(20(11-
15)
30-
4)
7-
8-
31(25,26)
13-
14-
5-
6-
18(28-
2)
17(9-
14)
22-
12-
21(23)
24;/h5-
11,22H,12-
13H2,1-
4H3,(H,23,24)
;/q;+1/p-
1/b8-
7+;
InChIKey
VLQLUZFVFXYXQE-USRGLUTNSA-M
SMILES
C1(=CC(=C(C(=C1)OC)/C=C/S(CC2=CC=C(C(=C2)NCC([O-])=O)OC)(=O)=O)OC)OC.[Na+]
Roles Classification
Biological Role
(s):
microtubule-destabilising agent
Any substance that interacts with tubulin to inhibit polymerisation of microtubules.
EC 2.7.11.21 (polo kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of any polo kinase (EC 2.7.11.21).
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application
(s):
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing
rigosertib sodium (
CHEBI:145421
)
has part
rigosertib(1−) (
CHEBI:145422
)
rigosertib sodium (
CHEBI:145421
)
has role
antineoplastic agent (
CHEBI:35610
)
rigosertib sodium (
CHEBI:145421
)
has role
apoptosis inducer (
CHEBI:68495
)
rigosertib sodium (
CHEBI:145421
)
has role
EC 2.7.11.21 (polo kinase) inhibitor (
CHEBI:145425
)
rigosertib sodium (
CHEBI:145421
)
has role
microtubule-destabilising agent (
CHEBI:61951
)
rigosertib sodium (
CHEBI:145421
)
is a
organic sodium salt (
CHEBI:38700
)
IUPAC Name
sodium [2-methoxy-5-({[(
E
)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)anilino]acetate
Synonyms
Sources
(
E
)-ON 01910.Na
ChEBI
novonex
ChemIDplus
ON 01910 sodium
ChEBI
ON 01910 sodium salt
ChemIDplus
ON 01910.Na
ChemIDplus
ON-01910 sodium
ChEBI
ON-01910 sodium salt
ChEBI
ON-01910.Na
ChEBI
rigosertib sodium salt
ChEBI
Brand Name
Source
Estybon
ChEBI
Manual Xrefs
Databases
D10155
KEGG DRUG
DBSALT002144
DrugBank
View more database links
Registry Number
Type
Source
592542-60-4
CAS Registry Number
ChemIDplus
Citations
Types
Sources
15766665
PubMed citation
Europe PMC
17588831
PubMed citation
Europe PMC
18955447
PubMed citation
Europe PMC
19029951
PubMed citation
Europe PMC
19466411
PubMed citation
Europe PMC
21646468
PubMed citation
Europe PMC
21812421
PubMed citation
Europe PMC
21924492
PubMed citation
Europe PMC
22351695
PubMed citation
Europe PMC
22524974
PubMed citation
Europe PMC
22678771
PubMed citation
Europe PMC
23386308
PubMed citation
Europe PMC
23486532
PubMed citation
Europe PMC
23738723
PubMed citation
Europe PMC
23841031
PubMed citation
Europe PMC
24493827
PubMed citation
Europe PMC
24748653
PubMed citation
Europe PMC
25316768
PubMed citation
Europe PMC
27150054
PubMed citation
Europe PMC
27764820
PubMed citation
Europe PMC
28985505
PubMed citation
Europe PMC
29423069
PubMed citation
Europe PMC
Last Modified
19 November 2019